Valuation: Divi's Laboratories Limited

Market Cap 2,272B 23.72B 20.48B 19.27B 17.52B 32.95B 33.43B 226B 88.6B 1,137B 89.05B 87.11B 3,786B P/E 2027 *
69.9x
P/E 2028 * 57.9x
Enterprise Value 2,237B 23.35B 20.17B 18.98B 17.25B 32.44B 32.91B 223B 87.23B 1,119B 87.67B 85.77B 3,727B EV / Sales 2027 *
17.8x
EV / Sales 2028 * 14.9x
Free-Float
48.01%
Yield 2027 *
0.41%
Yield 2028 * 0.45%
1 day-0.33%
1 week-0.22%
Current month+6.26%
1 month+18.11%
3 months+25.24%
6 months+36.23%
Current year+33.91%
1 week 8,414
Extreme 8414
8,630
1 month 7,177
Extreme 7177
8,674
Current year 5,647.5
Extreme 5647.5
8,674
1 year 5,636.5
Extreme 5636.5
8,674
3 years 3,295.3
Extreme 3295.3
8,674
5 years 2,730
Extreme 2730
8,674
10 years 532.65
Extreme 532.65
8,674
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%-0.22%+38.86%+134.21% 23.79B
+3.56%+3.67%+79.90%+129.99% 1,093B
+0.53%+4.70%+53.61%+63.20% 653B
+1.63%+5.60%+27.40%+74.94% 458B
+1.80%+0.52%+41.20%+44.48% 355B
+1.24%+2.35%+25.99%+41.24% 294B
+2.07%+2.97%+2.27%+12.89% 248B
+2.65%+5.08%+47.96%+67.74% 230B
+1.05%-0.02%-13.96%-52.51% 203B
+2.42%+7.96%+24.33%+93.17% 178B
Average +1.64%+1.09%+32.76%+60.93% 373.43B
Weighted average by Cap. +2.05%+1.45%+45.82%+73.20%

Financials

2027 *2028 *
Net sales 126B 1.31B 1.13B 1.07B 969M 1.82B 1.85B 12.5B 4.9B 62.85B 4.92B 4.82B 209B 150B 1.56B 1.35B 1.27B 1.16B 2.17B 2.2B 14.91B 5.84B 74.97B 5.87B 5.75B 250B
Net income 32.57B 340M 294M 276M 251M 472M 479M 3.24B 1.27B 16.29B 1.28B 1.25B 54.26B 39.37B 411M 355M 334M 303M 571M 579M 3.92B 1.53B 19.69B 1.54B 1.51B 65.58B
Net Debt -35B -365M -315M -297M -270M -507M -515M -3.48B -1.36B -17.5B -1.37B -1.34B -58.31B -44.85B -468M -404M -380M -346M -650M -660M -4.46B -1.75B -22.43B -1.76B -1.72B -74.72B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
19/08/26 INR 8,560.00 -0.33% 179,152
18/08/26 INR 8,588.00 +1.26% 404,163
17/08/26 INR 8,481.50 +0.05% 252,029
14/08/26 INR 8,477.00 -0.27% 340,336
13/08/26 INR 8,500.00 -1.16% 344,131
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
29
Last Close Price
8,588.00INR
Average target price
8,292.48INR
Spread / Average Target
-3.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock